[
    [
        {
            "time": "2023-05-13",
            "original_text": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 拟减持股份",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大股东",
                    "减持",
                    "同行股票"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 拟减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-13",
            "original_text": "天广中茂因触发面值退市情形 战略合作协议解除",
            "features": {
                "keywords": [
                    "天广中茂",
                    "面值退市",
                    "战略合作协议解除"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "天广中茂因触发面值退市情形 战略合作协议解除",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "沃森生物与艾博生物合作，共同开发带状疱疹、新冠病毒mRNA疫苗",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "mRNA疫苗",
                    "带状疱疹",
                    "新冠病毒"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物与艾博生物合作，共同开发带状疱疹、新冠病毒mRNA疫苗",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "沃森生物：携手艾博生物 开展带状疱疹、新冠病毒mRNA疫苗研究",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "mRNA疫苗",
                    "带状疱疹",
                    "新冠病毒"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：携手艾博生物 开展带状疱疹、新冠病毒mRNA疫苗研究",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "沃森生物现1笔大宗交易 共成交492.11万元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大宗交易"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物现1笔大宗交易 共成交492.11万元",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-12",
            "original_text": "恒瑞医药行贿丑闻背后：带金销售“肿瘤”待清除 其他违规处罚",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "行贿丑闻",
                    "带金销售",
                    "违规处罚"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药行贿丑闻背后：带金销售“肿瘤”待清除 其他违规处罚",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]